Pharmacokinetics And Safety Of A Single Dose Subcutaneous Or Intravenous Administration Of Tanezumab In Healthy Volunteers: An Open-Label, Non-Randomized Phase 1 Study.
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2009
At a glance
- Drugs Tanezumab; Tanezumab
- Indications Back pain; Cancer pain; Musculoskeletal pain; Neuralgia; Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 17 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2009 Planned number of patients changed from 72 to 76 as reported by ClinicalTrials.gov.
- 06 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.